BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Myriad Genetics CEO Paul Diaz to Speak at 40th Annual J.P. Morgan Health Care Conference

  Paul J. Diaz, president and CEO of Myriad Genetics (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will provide an update on the execution of the company’s strategic transformation and growth plans at the 40th Annual J.P. Morgan Health Care Conference at 2:15 p.m. ET on Jan. 11, 2022.

  January 5, 2022

   · 

  1 min read
• Pharm Country

  Tonix Pharmaceuticals to Participate in Upcoming January 2022 Conferences

  Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, announced that Seth Lederman, M.D., President and Chief Executive Officer of Tonix Pharmaceuticals, will participate in the H.C. Wainwright BioConnect Conference and the Biotech Showcase 2022, both being held virtually.

  January 5, 2022

   · 

  5 min read
• Pharm Country

  OraSure Technologies Announces Actions to Enhance Stockholder Value

  OraSure Technologies, Inc., a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced preliminary Q4 2021 results, organizational changes, and a Board-level review of strategic alternatives to enhance stockholder value.

  January 5, 2022

   · 

  13 min read
• Business

  Miromatrix Announces Two New Board Members

  Miromatrix Medical Inc. today announced the expansion of the board and appointment of two new board members: Lisa Wipperman Heine and William P. Burke.

  January 5, 2022

   · 

  5 min read
• BioForest

  Athira Pharma Provides 2022 Pipeline Outlook

  Topline data from ACT-AD Phase 2 Alzheimer’s disease study in 2Q22 LIFT-AD Phase 3 Alzheimer’s disease study sample size increased to strengthen statistical power of co-key secondary endpoints and enhance the potential for a single pivotal clinical study.

  January 5, 2022

   · 

  7 min read
• Business

  Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution

  Akoya Biosciences, Inc., and Bio-Techne today announced a partnership to develop the first single-cell, spatial multiomics workflow for comprehensive, unbiased analysis of tissue samples.

  January 5, 2022

   · 

  5 min read
• BioMidwest

  FluGen to Present at the 40th Annual J.P. Morgan Healthcare Conference

  FluGen, Inc., a clinical-stage vaccine company transforming vaccine efficacy in infectious respiratory diseases, today announced Boyd Clarke, Executive Chairman is scheduled to present at the 40th Annual J.P. Morgan Healthcare Conference.

  January 5, 2022

   · 

  1 min read
• Pertussis Vaccine Market: Growth in adoption of pertussis vaccination to drive the market

  Pertussis vaccine is used for whooping cough. This vaccine is available only in combination with other vaccines. Pertussis vaccination is recommended for all children, babies, teens, and pregnant women.

  January 5, 2022

   · 

  5 min read
• Peri-implantitis Market: Rise in the number of oral diseases to drive the market

  Dental implants has become an established therapy in dentistry essential to replace missing teeth in different clinical situations.

  January 5, 2022

   · 

  6 min read
• Patient Return Electrodes Market: Rise in number of electrosurgeries is projected to drive the market

  Electrosurgery involves generation of a circuit through a patient’s body in order to achieve surgical effects such as cutting, coagulation, desiccation, and fulguration of tissue.

  January 5, 2022

   · 

  4 min read